Table 1.
Name | P-value | NB4 expression | NB4 + ATRA expression | Map | TvsUT | Validation | Densitometry |
---|---|---|---|---|---|---|---|
hsa-mir-017-precNo2 | 0,0447 | 2,944 | 1,388 | 13q31 | Down | down | 6.0 fold |
hsa-mir-186-prec | 0,0447 | 0,864 | 0,891 | 1p31 | Up | up | 0.5 fold |
hsa-mir-193-precNo1 | 0,0385 | 1,031 | 0,847 | 17q11.2 | Down | down | 1.2 fold |
hsa-mir-195-prec | 0,0373 | 2,618 | 1,954 | 17p13 | Down | down | 0.8 fold |
hsa-mir-025-prec | 0,0351 | 7,56 | 3,157 | 7q22 | Down | down | 4.1 fold |
hsa-let-7a-1-prec | 0,0243 | 0,962 | 0,889 | 9q22.2 | Down | up | 3.2 fold |
hsa-mir-215-precNo2 | 0,0104 | 0,691 | 0,792 | 1q41 | Up | up | 0.5 fold |
hsa-mir-223-prec | 0.0232 | 8.68 | 17.08 | Xq12-13.3 | Up | up | 10.6 fold |
In the table are showed for each miRNA the name (hsa = human miRNAs), the P-value, the normalization of two independent experiment (NB4 = untreated; NB4-ATRA = treated); the locus map (map); the expression in treated versus untreated cells (T vs UT) and the expression (T vs UT) after northen blot validation (validation: up = upregulation; down = downregulation); the densitometry shows the average of three independent experiments.